vs

Side-by-side financial comparison of Corteva (CTVA) and Hershey Company (The) (HSY). Click either name above to swap in a different company.

Corteva is the larger business by last-quarter revenue ($3.9B vs $3.1B, roughly 1.3× Hershey Company (The)). Hershey Company (The) runs the higher net margin — 10.4% vs -14.1%, a 24.5% gap on every dollar of revenue. On growth, Hershey Company (The) posted the faster year-over-year revenue change (7.0% vs -1.7%). Corteva produced more free cash flow last quarter ($4.2B vs $788.5M). Over the past eight quarters, Hershey Company (The)'s revenue compounded faster (-2.5% CAGR vs -6.7%).

Corteva, Inc. is an American company devoted to products for seeds and crop protection, including herbicides, insecticides, fungicides, and biologicals that are sold in 110 countries. The company's name combines "cor" with "teva". It is headquartered in Indianapolis, Indiana. Corteva sells a large portion of their seeds under the Pioneer Hi-Bred International brand.

The Hershey Company, often called just Hershey or Hershey's, is an American multinational confectionery company headquartered in Hershey, Pennsylvania, which is also home to Hersheypark and Hershey's Chocolate World. The Hershey Company is one of the largest chocolate manufacturers in the world; it also manufactures baked products, such as cookies and cakes, and sells beverages like milkshakes, as well as other products. The Hershey Company was founded by Milton S. Hershey in 1894 as the Hers...

CTVA vs HSY — Head-to-Head

Bigger by revenue
CTVA
CTVA
1.3× larger
CTVA
$3.9B
$3.1B
HSY
Growing faster (revenue YoY)
HSY
HSY
+8.8% gap
HSY
7.0%
-1.7%
CTVA
Higher net margin
HSY
HSY
24.5% more per $
HSY
10.4%
-14.1%
CTVA
More free cash flow
CTVA
CTVA
$3.4B more FCF
CTVA
$4.2B
$788.5M
HSY
Faster 2-yr revenue CAGR
HSY
HSY
Annualised
HSY
-2.5%
-6.7%
CTVA

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CTVA
CTVA
HSY
HSY
Revenue
$3.9B
$3.1B
Net Profit
$-552.0M
$320.0M
Gross Margin
42.4%
37.0%
Operating Margin
-13.6%
14.4%
Net Margin
-14.1%
10.4%
Revenue YoY
-1.7%
7.0%
Net Profit YoY
-1246.3%
-59.8%
EPS (diluted)
$-0.80

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CTVA
CTVA
HSY
HSY
Q4 25
$3.9B
$3.1B
Q3 25
$2.6B
$3.2B
Q2 25
$6.5B
$2.6B
Q1 25
$4.4B
$2.8B
Q4 24
$4.0B
$2.9B
Q3 24
$2.3B
$3.0B
Q2 24
$6.1B
$2.1B
Q1 24
$4.5B
$3.3B
Net Profit
CTVA
CTVA
HSY
HSY
Q4 25
$-552.0M
$320.0M
Q3 25
$-320.0M
$276.3M
Q2 25
$1.3B
$62.7M
Q1 25
$652.0M
$224.2M
Q4 24
$-41.0M
$796.6M
Q3 24
$-524.0M
$446.3M
Q2 24
$1.1B
$180.9M
Q1 24
$419.0M
$797.5M
Gross Margin
CTVA
CTVA
HSY
HSY
Q4 25
42.4%
37.0%
Q3 25
37.2%
32.6%
Q2 25
54.6%
30.5%
Q1 25
47.0%
33.7%
Q4 24
37.3%
54.0%
Q3 24
32.7%
41.3%
Q2 24
52.3%
40.2%
Q1 24
43.2%
51.5%
Operating Margin
CTVA
CTVA
HSY
HSY
Q4 25
-13.6%
14.4%
Q3 25
-14.1%
13.7%
Q2 25
27.9%
7.4%
Q1 25
17.7%
13.2%
Q4 24
2.2%
32.5%
Q3 24
-27.2%
20.5%
Q2 24
21.9%
13.9%
Q1 24
10.7%
32.5%
Net Margin
CTVA
CTVA
HSY
HSY
Q4 25
-14.1%
10.4%
Q3 25
-12.2%
8.7%
Q2 25
20.4%
2.4%
Q1 25
14.8%
8.0%
Q4 24
-1.0%
27.6%
Q3 24
-22.5%
14.9%
Q2 24
17.2%
8.7%
Q1 24
9.3%
24.5%
EPS (diluted)
CTVA
CTVA
HSY
HSY
Q4 25
$-0.80
Q3 25
$-0.47
Q2 25
$1.92
Q1 25
$0.95
Q4 24
$-0.05
Q3 24
$-0.76
Q2 24
$1.51
Q1 24
$0.60

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CTVA
CTVA
HSY
HSY
Cash + ST InvestmentsLiquidity on hand
$4.5B
Total DebtLower is stronger
$1.7B
$4.7B
Stockholders' EquityBook value
$24.1B
$4.6B
Total Assets
$42.8B
$13.7B
Debt / EquityLower = less leverage
0.07×
1.01×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CTVA
CTVA
HSY
HSY
Q4 25
$4.5B
Q3 25
$2.6B
Q2 25
$2.1B
Q1 25
$2.0B
Q4 24
$3.2B
Q3 24
$2.5B
Q2 24
$2.0B
Q1 24
$1.7B
Total Debt
CTVA
CTVA
HSY
HSY
Q4 25
$1.7B
$4.7B
Q3 25
$1.7B
$4.7B
Q2 25
$1.7B
$5.2B
Q1 25
$1.8B
$5.2B
Q4 24
$2.0B
$3.2B
Q3 24
$2.0B
$3.2B
Q2 24
$2.5B
$3.5B
Q1 24
$2.5B
$3.8B
Stockholders' Equity
CTVA
CTVA
HSY
HSY
Q4 25
$24.1B
$4.6B
Q3 25
$25.2B
$4.6B
Q2 25
$25.9B
$4.5B
Q1 25
$24.3B
$4.7B
Q4 24
$23.8B
$4.7B
Q3 24
$24.7B
$4.2B
Q2 24
$25.2B
$4.0B
Q1 24
$24.8B
$4.1B
Total Assets
CTVA
CTVA
HSY
HSY
Q4 25
$42.8B
$13.7B
Q3 25
$42.2B
$13.6B
Q2 25
$41.8B
$13.6B
Q1 25
$42.1B
$14.0B
Q4 24
$40.8B
$12.9B
Q3 24
$41.9B
$12.6B
Q2 24
$41.5B
$12.4B
Q1 24
$43.6B
$12.4B
Debt / Equity
CTVA
CTVA
HSY
HSY
Q4 25
0.07×
1.01×
Q3 25
0.07×
1.02×
Q2 25
0.07×
1.15×
Q1 25
0.07×
1.11×
Q4 24
0.08×
0.68×
Q3 24
0.08×
0.76×
Q2 24
0.10×
0.87×
Q1 24
0.10×
0.92×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CTVA
CTVA
HSY
HSY
Operating Cash FlowLast quarter
$4.4B
$926.6M
Free Cash FlowOCF − Capex
$4.2B
$788.5M
FCF MarginFCF / Revenue
106.2%
25.5%
Capex IntensityCapex / Revenue
5.7%
4.5%
Cash ConversionOCF / Net Profit
2.90×
TTM Free Cash FlowTrailing 4 quarters
$2.8B
$1.8B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CTVA
CTVA
HSY
HSY
Q4 25
$4.4B
$926.6M
Q3 25
$193.0M
$841.9M
Q2 25
$947.0M
$112.2M
Q1 25
$-2.1B
$396.7M
Q4 24
$4.2B
$941.6M
Q3 24
$130.0M
$695.3M
Q2 24
$451.0M
$325.6M
Q1 24
$-2.6B
$569.1M
Free Cash Flow
CTVA
CTVA
HSY
HSY
Q4 25
$4.2B
$788.5M
Q3 25
$36.0M
$756.0M
Q2 25
$829.0M
$27.1M
Q1 25
$-2.2B
$251.2M
Q4 24
$4.0B
$807.1M
Q3 24
$-24.0M
$567.3M
Q2 24
$337.0M
$195.5M
Q1 24
$-2.8B
$355.8M
FCF Margin
CTVA
CTVA
HSY
HSY
Q4 25
106.2%
25.5%
Q3 25
1.4%
23.8%
Q2 25
12.8%
1.0%
Q1 25
-49.9%
9.0%
Q4 24
100.4%
28.0%
Q3 24
-1.0%
19.0%
Q2 24
5.5%
9.4%
Q1 24
-61.4%
10.9%
Capex Intensity
CTVA
CTVA
HSY
HSY
Q4 25
5.7%
4.5%
Q3 25
6.0%
2.7%
Q2 25
1.8%
3.3%
Q1 25
2.1%
5.2%
Q4 24
4.6%
4.7%
Q3 24
6.6%
4.3%
Q2 24
1.9%
6.3%
Q1 24
3.3%
6.6%
Cash Conversion
CTVA
CTVA
HSY
HSY
Q4 25
2.90×
Q3 25
3.05×
Q2 25
0.72×
1.79×
Q1 25
-3.23×
1.77×
Q4 24
1.18×
Q3 24
1.56×
Q2 24
0.43×
1.80×
Q1 24
-6.23×
0.71×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CTVA
CTVA

Corn$1.4B35%
Herbicides$1.1B27%
Insecticides$488.0M12%
Fungicides$272.0M7%
Biologicals$191.0M5%
Soybean$164.0M4%
Other$160.0M4%
Otheroilseeds$94.0M2%

HSY
HSY

Other$1.8B59%
North America Salty Snacks Segment$1.3B41%

Related Comparisons